Form 4 for BBIO BridgeBio Pharma, Inc.
Accepted 2025-05-06 00:00:00 ET · period of report 2025-05-02 · accession 0000950170-25-064567 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-06 | 2025-05-02 | BBIO | Apuli Maricel | CAO | S - Sale | $38.51 | -1,026 | 147.6K | -0.7% | -$39.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-02 | S | D | 1,026 | $38.51 | 147,639 | D | — | — |